Janumet

In the US, Janumet (metformin/sitagliptin systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

• Janumet

Ingredient matches for Janumet

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Janumet in the following countries:

• Australia


• Austria


• Denmark


• France


• Germany


• Greece


• Ireland


• Netherlands


• Norway


• Peru


• Spain


• Sweden


• Switzerland


• United States

Sitagliptin

Sitagliptin phosphate hydrate (a derivative of Sitagliptin) is reported as an ingredient of Janumet in the following countries:

• Australia


• Austria


• Denmark


• France


• Germany


• Greece


• Ireland


• Netherlands


• Norway


• Peru


• Spain


• Sweden


• Switzerland


• United States

International Drug Name Search